Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Acta Psychiatr Scand
1 Clin Neuropharmacol
1 Compr Psychiatry
3 J Abnorm Psychol
1 J Clin Psychopharmacol
4 Mol Psychiatry
1 PLoS Comput Biol
1 PLoS One
4 Psychiatry Res
14 Psychol Med
1 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Psychiatr Scand

  1. LOPEZ-DIAZ A, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3-year longitudinal study.
    Acta Psychiatr Scand. 2021;144:578-588.
    PubMed         Abstract available

    Clin Neuropharmacol

  2. PUJAL RODRIGUEZ E, Pons-Cabrera MT, Gimenez A, Colomer L, et al
    Perampanel-Induced Psychosis in a Young Woman: A Case Report.
    Clin Neuropharmacol. 2021;44:240-242.
    PubMed         Abstract available

    Compr Psychiatry

  3. AISSA A, Jouini R, Ouali U, Zgueb Y, et al
    Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia.
    Compr Psychiatry. 2021;112:152280.
    PubMed         Abstract available

    J Abnorm Psychol

  4. LONGENECKER JM, Pokorny VJ, Kang SS, Olman CA, et al
    Self-reported perceptual aberrations in psychosis map to event-related potentials and semantic appraisals of objects.
    J Abnorm Psychol. 2021;130:785-796.
    PubMed         Abstract available

  5. FOERSTER FR, Weibel S, Poncelet P, Dufour A, et al
    Volatility of subliminal haptic feedback alters the feeling of control in schizophrenia.
    J Abnorm Psychol. 2021;130:775-784.
    PubMed         Abstract available

  6. WUSTEN C, Lincoln TM
    Cross-cultural comparisons of the effect of a schizophrenia label on stigmatizing family attitudes: A case vignette study.
    J Abnorm Psychol. 2021 Nov 11. pii: 2022-02067-001. doi: 10.1037/abn0000708.
    PubMed         Abstract available

    J Clin Psychopharmacol

  7. MAKHLOUF AT, Van Alphen MU, Manzano GS, Freudenreich O, et al
    A Seizure After COVID-19 Vaccination in a Patient on Clozapine.
    J Clin Psychopharmacol. 2021;41:689-690.

    Mol Psychiatry

  8. NOTARAS M, Lodhi A, Dundar F, Collier P, et al
    Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids.
    Mol Psychiatry. 2021 Nov 17. pii: 10.1038/s41380-021-01316.
    PubMed         Abstract available

  9. EISENBERG DP, Kohn PD, Hegarty CE, Smith NR, et al
    Clinical correlation but no elevation of striatal dopamine synthesis capacity in two independent cohorts of medication-free individuals with schizophrenia.
    Mol Psychiatry. 2021 Nov 17. pii: 10.1038/s41380-021-01337.
    PubMed         Abstract available

  10. PLAVEN-SIGRAY P, Ikonen Victorsson P, Santillo A, Matheson GJ, et al
    Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.
    Mol Psychiatry. 2021 Nov 10. pii: 10.1038/s41380-021-01349.
    PubMed         Abstract available

  11. CUENOD M, Steullet P, Cabungcal JH, Dwir D, et al
    Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.
    Mol Psychiatry. 2021 Nov 10. pii: 10.1038/s41380-021-01374.
    PubMed         Abstract available

    PLoS Comput Biol

  12. DENG Y, Pan W
    Model checking via testing for direct effects in Mendelian Randomization and transcriptome-wide association studies.
    PLoS Comput Biol. 2021;17:e1009266.
    PubMed         Abstract available

    PLoS One

  13. MARTIN J, Asjadi K, Hubbard L, Kendall K, et al
    Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.
    PLoS One. 2021;16:e0248254.
    PubMed         Abstract available

    Psychiatry Res

  14. GALLOS IK, Mantonakis L, Spilioti E, Kattoulas E, et al
    The relation of integrated psychological therapy to resting state functional brain connectivity networks in patients with schizophrenia.
    Psychiatry Res. 2021;306:114270.
    PubMed         Abstract available

  15. SANTOS MJ, Ferreira TF, Sequeira M, Trancas B, et al
    Chronic hallucinatory psychosis presenting with olfactory hallucinations: A case report.
    Psychiatry Res. 2021;305:114262.

  16. RUSSO M, Consoli S, De Rosa MA, Calisi D, et al
    A case of Sars-Cov-2-related mania with prominent psychosis>.
    Psychiatry Res. 2021;306:114266.

  17. LYU J, Zhang J
    Suicide means, timing, intent and behavior characteristics of the suicides with schizophrenia.
    Psychiatry Res. 2021;306:114267.
    PubMed         Abstract available

    Psychol Med

  18. LIU Y, Mendonca M, Johnson S, O'Reilly H, et al
    Testing the neurodevelopmental, trauma and developmental risk factor models of psychosis using a naturalistic experiment.
    Psychol Med. 2021;51:460-469.
    PubMed         Abstract available

  19. HJORTHOJ C, Uddin MJ, Wimberley T, Dalsgaard S, et al
    No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder.
    Psychol Med. 2021;51:479-484.
    PubMed         Abstract available

  20. MARTIN-SUBERO M, Fuentes-Claramonte P, Salgado-Pineda P, Salavert J, et al
    Autobiographical memory and default mode network function in schizophrenia: an fMRI study.
    Psychol Med. 2021;51:121-128.
    PubMed         Abstract available

  21. BRUCATO G, First MB, Dishy GA, Samuel SS, et al
    Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
    Psychol Med. 2021;51:112-120.
    PubMed         Abstract available

  22. SMART SE, Kepinska AP, Murray RM, MacCabe JH, et al
    Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.
    Psychol Med. 2021;51:44-53.
    PubMed         Abstract available

  23. HJORTHOJ C, Larsen MO, Starzer MSK, Nordentoft M, et al
    Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.
    Psychol Med. 2021;51:617-622.
    PubMed         Abstract available

  24. ZHANG T, Xu L, Li H, Woodberry KA, et al
    Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program.
    Psychol Med. 2021;51:653-660.
    PubMed         Abstract available

  25. HERBENER ES, Harrow M
    Course and symptom and functional correlates of passivity symptoms in schizophrenia: an 18-year multi-follow-up longitudinal study.
    Psychol Med. 2021;51:503-510.
    PubMed         Abstract available

  26. NKIRE N, Scully PJ, Browne DJ, Baldwin PA, et al
    Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Psychol Med. 2021;51:607-616.
    PubMed         Abstract available

  27. HUANG MH, Cheng CM, Tsai SJ, Bai YM, et al
    Familial coaggregation of major psychiatric disorders among first-degree relatives of patients with obsessive-compulsive disorder: a nationwide study.
    Psychol Med. 2021;51:680-687.
    PubMed         Abstract available

  28. O'NEILL A, Wilson R, Blest-Hopley G, Annibale L, et al
    Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
    Psychol Med. 2021;51:596-606.
    PubMed         Abstract available

  29. MERCHANT JT, Moran EK, Strube MJ, Barch DM, et al
    Correlates of real-world goal-directed behavior in schizophrenia.
    Psychol Med. 2021 Nov 12:1-9. doi: 10.1017/S0033291721004281.
    PubMed         Abstract available

  30. ERZIN G, Pries LK, Dimitrakopoulos S, Ralli I, et al
    Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens first-episode psychosis research study.
    Psychol Med. 2021 Nov 18:1-10. doi: 10.1017/S0033291721004542.
    PubMed         Abstract available

  31. BRAND BA, Haveman YRA, de Beer F, de Boer JN, et al
    Antipsychotic medication for women with schizophrenia spectrum disorders.
    Psychol Med. 2021 Nov 12:1-15. doi: 10.1017/S0033291721004591.
    PubMed         Abstract available

    Schizophr Res

  32. MOTA NB
    Commentary on "Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations": The current need for the harmonization of speech elicitation protocols in basic and applied science.
    Schizophr Res. 2021;238:199-200.

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.